Significant Differential Effects of Alendronate, Estrogen, or Combination Therapy on the Rate of Bone Loss after Discontinuation of Treatment of Postmenopausal Osteoporosis
- 3 December 2002
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 137 (11) , 875-883
- https://doi.org/10.7326/0003-4819-137-11-200212030-00008
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Biological Variability of Serum and Urinary N-Telopeptides of Type I Collagen in Postmenopausal WomenJournal of Bone and Mineral Research, 2000
- Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal WomenThe American Journal of Medicine, 1997
- Diurnal Variation of Bone Mineral Turnover in Elderly Men and WomenCalcified Tissue International, 1997
- Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective studyJournal of Bone and Mineral Research, 1996
- The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly WomenNew England Journal of Medicine, 1993
- Compliance with hormone therapyAmerican Journal of Obstetrics and Gynecology, 1987
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981